Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitra Papadopoulou

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Translational Medicine|April 24, 2021
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatmentLydia Ntari, Christoforos Nikolaou, Ksanthi Kranidioti, et al.
Elife|September 5, 2024
<i>Mir221/222</i> drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling componentsFani Roumelioti, Christos Tzaferis, Dimitris Konstantopoulos, et al.
JCI Insight|April 4, 2023
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritisDimitra Papadopoulou, Fani Roumelioti, Christos Tzaferis, et al.
Angewandte Chemie (International Ed. in English)|February 10, 2024
Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast ActivationDimitra Papadopoulou, Vasiliki Mavrikaki, Filippos Charalampous, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Translational Medicine|April 24, 2021
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatmentLydia Ntari, Christoforos Nikolaou, Ksanthi Kranidioti, et al.
Elife|September 5, 2024
<i>Mir221/222</i> drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling componentsFani Roumelioti, Christos Tzaferis, Dimitris Konstantopoulos, et al.
JCI Insight|April 4, 2023
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritisDimitra Papadopoulou, Fani Roumelioti, Christos Tzaferis, et al.
Angewandte Chemie (International Ed. in English)|February 10, 2024
Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast ActivationDimitra Papadopoulou, Vasiliki Mavrikaki, Filippos Charalampous, et al.
Pageof 2